UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

Item
http://www.wikidata.org/entity/Q36028992
Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.Six-year outcomes in neovascular age-related macular degeneration with ranibizumab.Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care.UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK.Big Data and Uveitis.Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence.UK ophthalmology electronic medical records, databases, big data, and Robert L Johnston!Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan.Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study.
P2860

UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12

Item
http://www.wikidata.org/entity/Q36028992
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@ast
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@en
type
label
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@ast
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@en
prefLabel
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@ast
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
UK AMD EMR USERS GROUP REPORT ...... s with vision better than 6/12
@en
P2093
P2860
P304
P31
P356
10.1136/BJOPHTHALMOL-2014-306229
P407
P433
P478
P50
P577
P5875
P698
P932